NL-OMON27363招募中不适用
Studying coagulation specific for COVID-19 using Blood-vessel-on-chip technology.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- ZonMw
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age of 18 years or older
- •- A suspected SARS-CoV-2 virus infection
- •- Need for oxygen supplementation
- •- CRP level > 50 mg/L
- •- D-dimer level > 0.5 mg/L
- •- Ability to provide written informed consent
排除标准
- •- History of venous thromboembolism
- •- Use of anticoagulant therapy at inclusion
- •- Known hereditary or acquired thrombophilia
研究者
相似试验
招募中
不适用
Studying coagulation in COVID-19 using blood-vessel-on-chip technology.NL-OMON51031Academisch Medisch Centrum36
尚未招募
不适用
A study of blood group in COVID-19 patients admitted at tertiary care hospital, AhmedabadCTRI/2021/01/030344Arpit Prajapati
已完成
不适用
Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) PatientsCovid19NCT04982263Sohag University125
招募中
不适用
Assessment of coagulation status in patients undergoing cardiac surgery with cardiopulmonary bypassAdult patients undergoing elective cardiac valve surgery with cardiopulmonary bypassJPRN-UMIN000041097Jichi Medical University, Saitama Medical Center30
进行中（未招募）
1 期
A Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 PandemicCoagulopathy of COVID-19 appears to afflict approximately 20% of patients with severe COVID-19 and is associated with need for critical care and death. COVID-19 coagulopathy is characterized by elevated D-dimer, an indicator of fibrin formation and clot lysis, and a mildly prolonged prothrombin time (PT), suggestive of coagulation consumptionEUCTR2020-002190-10-IEniversity College Dublin24